[HTML][HTML] Cost-effectiveness and cost-utility analyses of dabigatran compared with warfarin in patients with nonvalvular atrial fibrillation and risk factors for stroke and …
CPR de Souza, NB Santoni, TG de Melo… - Value in health regional …, 2015 - Elsevier
Objective To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and …
T Gomes de Melo… - Value in Health Regional …, 2015 - europepmc.org
Objective To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
Cost-effectiveness and cost-utility analyses of dabigatran compared with warfarin in patients with non valvular atrial fibrillation and risk factors for stroke and systemic …
CPR Souza, NB Santoni, TG Melo… - Value Health Reg …, 2015 - pesquisa.bvsalud.org
Objective: To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with non valvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with non valvular atrial fibrillation with moderate to high risk of ischemic …
[HTML][HTML] Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke …
CPR de Souza, NB Santoni… - Value in Health …, 2015 - valuehealthregionalissues.com
Objective To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and …
CPR de Souza, NB Santoni… - Value in health …, 2015 - pubmed.ncbi.nlm.nih.gov
Objective To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
[PDF][PDF] Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke …
MJ de Oliveira Figueiredo, FC da Costa Darrieux… - 2015 - core.ac.uk
Objective: To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and …
CPR de Souza, NB Santoni, TG de Melo… - Value in Health …, 2015 - infona.pl
To analyze the cost-effectiveness and cost-utility of dabigatran compared with warfarin in
patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic stroke or …
patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic stroke or …
[PDF][PDF] Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke …
MJ de Oliveira Figueiredo, FC da Costa Darrieux… - 2015 - cyberleninka.org
Objective: To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
[PDF][PDF] Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke …
MJ de Oliveira Figueiredo, FC da Costa Darrieux… - 2015 - researchgate.net
Objective: To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …
Cost-effectiveness and cost-utility analyses of dabigatran compared with warfarin in patients with non valvular atrial fibrillation and risk factors for stroke and systemic …
CPR Souza, NB Santoni, TG Melo… - Value Health Reg …, 2015 - pesquisa.bvsalud.org
Objective: To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with non valvular atrial fibrillation with moderate to high risk of ischemic …
warfarin in patients with non valvular atrial fibrillation with moderate to high risk of ischemic …